{"id":"https://openalex.org/W2979200427","doi":null,"title":"Long term efficacy of pegylated \u0131nterferone in the treatment of delta hepatitis: a single center experience.","display_name":"Long term efficacy of pegylated \u0131nterferone in the treatment of delta hepatitis: a single center experience.","publication_year":2016,"publication_date":"2016-07-01","ids":{"openalex":"https://openalex.org/W2979200427","mag":"2979200427","pmid":"https://pubmed.ncbi.nlm.nih.gov/27821029"},"language":"en","primary_location":{"id":"pmid:27821029","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27821029","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta gastro-enterologica Belgica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Z M Y K\u0131l\u0131\u00e7","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z M Y K\u0131l\u0131\u00e7","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047914939","display_name":"Ayd\u0131n \u015eeref K\u00f6ksal","orcid":"https://orcid.org/0000-0001-5623-6109","observed_orcids":["https://orcid.org/0000-0001-5623-6109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A S K\u00f6ksal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074052241","display_name":"I H Kalkan","orcid":"https://orcid.org/0009-0007-1675-6426","observed_orcids":["https://orcid.org/0009-0007-1675-6426","https://orcid.org/0000-0002-0390-8220"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I H Kalkan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016240819","display_name":"Nuretdin Suna","orcid":"https://orcid.org/0000-0001-6234-7788","observed_orcids":["https://orcid.org/0000-0001-6234-7788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Suna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100764684","display_name":"Hakan Y\u0131ld\u0131z","orcid":"https://orcid.org/0000-0002-3459-5669","observed_orcids":["https://orcid.org/0000-0002-3459-5669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Y\u0131ld\u0131z","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047958397","display_name":"Sabite Ka\u00e7ar","orcid":"https://orcid.org/0000-0002-3257-3546","observed_orcids":["https://orcid.org/0000-0002-3257-3546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Kacar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2467,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.54326557,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"79","issue":"2","first_page":"329","last_page":"335"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12025","display_name":"Hepatitis Viruses Studies and Epidemiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.8339999914169312},{"id":"https://openalex.org/keywords/chronic-hepatitis-d","display_name":"chronic hepatitis D","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hepatitis-d","display_name":"hepatitis D","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hdv-rna","display_name":"HDV RNA","score":0.6100000143051147},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8970000147819519},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7009999752044678},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.9390000104904175},{"id":"https://openalex.org/keywords/interferon-alfa-2a","display_name":"interferon alfa-2a","score":0.8460000157356262},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9570000171661377},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.8980000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8222924470901489},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.667746901512146},{"id":"https://openalex.org/C2908824246","wikidata":"https://www.wikidata.org/wiki/Q327281","display_name":"HEPATITIS DELTA","level":4,"score":0.6186582446098328},{"id":"https://openalex.org/C2776699657","wikidata":"https://www.wikidata.org/wiki/Q327281","display_name":"Hepatitis D","level":5,"score":0.5498967170715332},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.4794248938560486},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44476354122161865},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3788517713546753},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.21923497319221497},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15201810002326965},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.08609846234321594},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003699","descriptor_name":"Hepatitis D","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:27821029","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27821029","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta gastro-enterologica Belgica","raw_type":"Journal Article"},{"id":"pmh:oai:acikerisim.sakarya.edu.tr:20.500.12619/67064","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/20.500.12619/67064","pdf_url":null,"source":{"id":"https://openalex.org/S7407055276","display_name":"Sakarya \u00dcniversitesi Kurumsal A\u00e7\u0131k Akademik Ar\u015fivi","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"mag:2979200427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27821029","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7162347308","https://openalex.org/W176023137","https://openalex.org/W2065614359","https://openalex.org/W3164902771","https://openalex.org/W2166256081","https://openalex.org/W2010852150","https://openalex.org/W2060563877","https://openalex.org/W4245966549","https://openalex.org/W3044569778","https://openalex.org/W2406370820"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"AIM:":[2],"Currently":[3],"there":[4],"is":[5],"no":[6],"satisfactory":[7],"treatment":[8,41,58,92,105,126,154,164,183],"of":[9,20,40,57,67,91,121,153,161,163,184,187],"chronic":[10,29],"HDV.":[11],"We":[12],"aimed":[13],"to":[14],"evaluate":[15],"the":[16,134,143,171,182,192],"long":[17,51,144,172,193],"term":[18,52],"efficacy":[19,53,180],"PEG-interferones.":[21],"PATIENTS":[22],"METHODS:":[23],"Patients":[24],"who":[25],"received":[26,72],"PEG-interferone":[27,74,78,104,125],"for":[28,81,117],"delta":[30],"hepatitis":[31],"during":[32,133],"a":[33,118,188],"7-year":[34],"period":[35],"were":[36,54,60,115,158],"retrospectively":[37],"analysed.":[38],"End":[39],"response,":[42],"virologic":[43,93,137,168],"response":[44,59,94,138,157,165,169],"at":[45,82,150],"6":[46,101],"months":[47,102,123],"after":[48,100,124],"treatment,":[49],"and":[50,155,166],"evaluated.":[55],"Predictors":[56],"determined.":[61],"RESULTS:":[62],"The":[63,113],"study":[64],"group":[65],"consisted":[66],"31":[68],"patients.":[69],"Twenty-three":[70],"patients":[71,87,110,114,130],"either":[73],"alfa-2a":[75],"(n=8)":[76],"or":[77],"alfa-2b":[79],"(n=15)":[80],"least":[83],"48":[84],"weeks.":[85],"Thirteen":[86],"had":[88],"an":[89,178],"end":[90,162],"(ITT:56.5%,":[95],"PP:68.4%).":[96],"HDV":[97,147,185],"RNA":[98,148],"negativity":[99],"off":[103],"was":[106,140],"achieved":[107],"in":[108,142,170,191],"12":[109],"(ITT:52.1%,":[111],"PP:63.1%).":[112],"followed":[116],"median":[119],"duration":[120],"36":[122],"(min-max:12-120":[127],"months).":[128],"Four":[129],"(33.3%)":[131],"relapsed":[132],"follow-up.":[135],"Sustained":[136],"(ITT)":[139],"34.8%":[141],"term.":[145,194],"Undetectable":[146],"level":[149],"week":[151],"24":[152],"biochemical":[156],"independent":[159],"predictors":[160],"sustained":[167],"term,":[173],"respectively.":[174],"CONCLUSION:":[175],"PEG-interferones":[176],"have":[177],"unsatisfactory":[179],"on":[181],"because":[186],"considerable":[189],"relapse":[190],"(Acta":[195],"gastro-enterol.":[196],"belg.,":[197],"2016,":[198],"79,":[199],"329-335).":[200]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-10T00:00:00"}